Booz Allen Hamilton (NYSE:BAH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.
According to Zacks, “Booz Allen Hamilton Inc. is engaged in providing management and technology consulting services to the U.S. government in the defense, intelligence and civil markets. Technological services offered by the Company include Cyber technologies, SE&I, Systems development and Strategic technology and innovation. Its major clients include the Department of Defense, all branches of the U.S. military, the U.S. Intelligence Community, and civil agencies such as the Department of Homeland Security, the Department of Energy, the Department of Health and Human Services, the Department of the Treasury and the Environmental Protection Agency. Booz Allen Hamilton Inc. is headquartered in McLean, Virginia, the United States of America. “
Several other research firms have also issued reports on BAH. Cowen reaffirmed a “buy” rating and issued a $50.00 price target (up previously from $41.00) on shares of Booz Allen Hamilton in a research report on Thursday, October 12th. ValuEngine lowered Booz Allen Hamilton from a “buy” rating to a “hold” rating in a research report on Saturday, November 4th. SunTrust Banks assumed coverage on Booz Allen Hamilton in a research report on Friday, December 1st. They issued a “buy” rating and a $47.00 target price for the company. Stifel Nicolaus assumed coverage on Booz Allen Hamilton in a research report on Tuesday, November 21st. They issued a “buy” rating and a $46.00 target price for the company. Finally, Wells Fargo & Co boosted their target price on Booz Allen Hamilton from $40.00 to $42.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 25th. Seven equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $41.32.
Booz Allen Hamilton (NYSE:BAH) last posted its quarterly earnings results on Monday, February 5th. The business services provider reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.52 billion. Booz Allen Hamilton had a return on equity of 50.81% and a net margin of 4.68%. Booz Allen Hamilton’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.38 EPS. equities analysts anticipate that Booz Allen Hamilton will post 1.93 EPS for the current fiscal year.
In other Booz Allen Hamilton news, CFO Lloyd Howell, Jr. sold 11,745 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $39.50, for a total transaction of $463,927.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Susan L. Penfield sold 30,022 shares of the business’s stock in a transaction dated Wednesday, December 6th. The shares were sold at an average price of $38.31, for a total value of $1,150,142.82. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 182,135 shares of company stock valued at $7,226,660. Corporate insiders own 3.04% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the business. Cerebellum GP LLC bought a new stake in shares of Booz Allen Hamilton during the 4th quarter valued at about $126,000. American International Group Inc. bought a new stake in shares of Booz Allen Hamilton during the 4th quarter valued at about $128,000. Advisor Group Inc. grew its stake in shares of Booz Allen Hamilton by 13.1% during the 2nd quarter. Advisor Group Inc. now owns 3,497 shares of the business services provider’s stock valued at $113,000 after acquiring an additional 405 shares during the period. The Manufacturers Life Insurance Company grew its stake in shares of Booz Allen Hamilton by 8.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 4,603 shares of the business services provider’s stock valued at $150,000 after acquiring an additional 347 shares during the period. Finally, Camelot Portfolios LLC bought a new position in shares of Booz Allen Hamilton during the 4th quarter valued at approximately $220,000. Institutional investors and hedge funds own 92.70% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Booz Allen Hamilton (BAH) Stock Rating Lowered by Zacks Investment Research” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/11/booz-allen-hamilton-bah-stock-rating-lowered-by-zacks-investment-research.html.
About Booz Allen Hamilton
Booz Allen Hamilton Holding Corporation is a holding company. The Company is a provider of management and technology, consulting and engineering services to the United States and international governments, corporations and not-for-profit organizations. The Company’s client base includes government, commercial and international clients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Booz Allen Hamilton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booz Allen Hamilton and related companies with MarketBeat.com's FREE daily email newsletter.